No matter how good the biohealth deal may appear to be I can't help but feel this will have a negative effect on the SP compared to what was initially on offer. Owning the MM facility, infrastructure and licences had an intrinsic value for our company that couldn't be denied. Now we have MOU in place of this... I'm sure Sholom is all over this but they are going to have to bring something pretty special to the table between now and relisting to convince Mr Market that, that perceived value is still there.
CGB Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held